BRIEF published on 08/20/2025 at 18:05, 3 months 15 days ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de directeur financier Directeur Financier Planification Stratégique OSE Immunotherapeutics Financement Des Biotechnologies Thomas Gidoin
BRIEF published on 08/20/2025 at 18:05, 3 months 15 days ago OSE Immunotherapeutics Appoints Thomas Gidoin as CFO Chief Financial Officer Strategic Planning Biotech Financing OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 3 months 15 days ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier Nomination de Thomas Gidoin comme nouveau Directeur Financier chez OSE Immunotherapeutics. Il apporte 15 ans d'expertise internationale en finance et gouvernance Biotechnologie Finance Directeur Financier OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 3 months 15 days ago OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer OSE Immunotherapeutics appoints Thomas Gidoin as Chief Financial Officer, bringing deep expertise in capital markets and financial strategy to the company. Gidoin succeeds Anne-Laure Autret-Cornet Chief Financial Officer Capital Markets Financial Strategy OSE Immunotherapeutics Thomas Gidoin
BRIEF published on 07/02/2025 at 08:05, 5 months 3 days ago OSE Immunotherapeutics Updates on Legal Proceedings Transparency Shareholder Meeting Legal Proceedings OSE Immunotherapeutics Nantes Commercial Court
BRIEF published on 07/02/2025 at 08:05, 5 months 3 days ago Mises à jour d'OSE Immunotherapeutics sur les procédures judiciaires Transparence Assemblée Des Actionnaires OSE Immunotherapeutics Procédures Judiciaires Tribunal De Commerce De Nantes
PRESS RELEASE published on 07/02/2025 at 08:00, 5 months 3 days ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours OSE Immunotherapeutics provides an update on ongoing legal proceedings regarding shareholders' motions, confirms plans for annual shareholders' meeting on September 30, 2025 Shareholders Biotech Annual Meeting Legal Proceedings OSE Immunotherapeutics
PRESS RELEASE published on 07/02/2025 at 08:00, 5 months 3 days ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours Mise à jour des procédures en cours par OSE Immunotherapeutics concernant une action en justice et la tenue de leur assemblée générale annuelle. Vision prospective de l'entreprise Biotechnologie Procédures En Cours Déclarations Prospectives Assemblée Générale Annuelle OSE Immunotherapeutics
BRIEF published on 06/20/2025 at 19:35, 5 months 14 days ago OSE Immunotherapeutics sécurise son Assemblée Générale Actionnaires Assemblée Générale Transparence OSE Immunotherapeutics Procédures Judiciaires
BRIEF published on 06/20/2025 at 19:35, 5 months 14 days ago OSE Immunotherapeutics secures its General Meeting Shareholders Transparency General Assembly Legal Proceedings OSE Immunotherapeutics
Published on 12/05/2025 at 02:35, 10 hours 39 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 14 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 9 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 14 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 13 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 13 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 8 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 13 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 13 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 29 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 29 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 31 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 59 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 14 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
